Localized bowel vasculitis: Postoperative cyclophosphamide or not?

Arthritis and Rheumatism

Volumn 42, Issue 1, 1999, Pages 182-185

  Raza, K ^a   Exley, A R ^a   Carruthers, D M ^a   Buckley, C ^a   Hammond, L A ^a   Bacon, P A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CYCLOPHOSPHAMIDE; DIGOXIN; FUROSEMIDE; HEPARIN; VITAMIN K GROUP; WARFARIN;

ADULT; ARTICLE; CASE REPORT; CHRONIC INFLAMMATION; CLINICAL FEATURE; FEMALE; HEPARINIZATION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE NECROSIS; MALE; POLYARTERITIS NODOSA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; TISSUE DISTRIBUTION; TREATMENT INDICATION; TREATMENT PLANNING; VASCULITIS;

ADULT; COLON; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; VASCULITIS;

EID: 0032944447     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199901)42:1<182::AID-ANR22>3.0.CO;2-4     Document Type: Article

References (16)

1. Fauci AS, Katz P, Haynes BF, Wolff SM. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 1979;301:235-8.
2. Hoffman GS, Kerr GS, Leavilt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
3. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
4. Guillevin L, Lhote F. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects and treatment. Rheum Dis Clin North Am 1995;21:911-47.
5. Camilleri M, Pusey CD, Chadwick VS, Rees AJ. Gastrointestinal manifestations of systemic vasculitis. QJM 1983;206:141-9.
6. Burke AP, Sobin LH, Virmani R. Localized vasculitis of the gastrointestinal tract. Am J Surg Pathol 1995;19:338-49.
7. Shurbaji MS, Epstein JI. Testicular vasculitis: implications for systemic disease. Hum Pathol 1988;19:186-9.
8. Ito M, Sano K, Inaha H, Hotchi M. Localized necrotizing arteritis. Arch Pathol Lab Med 1991;115:780-3.
9. Weyand CM, Goronzy JJ. Multisystem interactions in the pathogenesis of vasculitis. Curr Opin Rheumatol 1997;9:3-11.
10. Weyand CM, Wagner AD, Björnsson J, Goronzy JJ. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest 1996;98:1642-9.
11. Qasim FJ, Thiru S, Mathieson PW, Oliveira DBG. The time course and characterisation of mercuric chloride-induced immunopathology in the brown Norway rat. J Autoimmun 1995;8:193-208.
12. Salmon M, Pilling D, Borthwick NJ, Akbar AN. Inhibition of T-cell apoptosis - a mechanism for persistence in chronic inflammation. Immunologist 1997;5:87-92.
13. Berger JR, Romano J, Menkin M, Norenberg M. Benign focal cerebral vasculitis: case report. Neurology 1995;45:1731-4.
14. Gordon M, Luqmani RA, Adu D, Greaves I, Richards N, Michael J, et al. Relapses in patients with a systemic vasculitis. QJM 1993;86:779-89.
15. Exley AR, Carruthers DM, Luqmani RA, Kitas GD, Gordon C, Janssen BA, et al. Damage occurs early in systemic vasculitis and is an index of outcome. QJM 1997;90:391-9.
16. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8.